Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Clinical trial NCT00787761 · COMPLETED

Trial details

NCT number: NCT00787761
Sponsor: Northside Hospital, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myeloproliferative Disorders Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases

Start date: 2007-04-01
Primary completion: 2010-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.